Biomarin Pharmaceutical

Biomarin Pharmaceutical

Community score

+1.12 -55
Industry: Biotechnology & Pharmaceuticals
Listing country: United States
Year added: 2018

BioMarin Pharmaceutical Inc. was established in 1997 and has since positioned itself as a notable player in the biotechnology and pharmaceutical sectors. Specializing in innovative therapies for rare genetic disorders, the company is headquartered in San Rafael, California, United States. It focuses on enzyme replacement therapies among other drug developments tailored to particular medical needs. With a portfolio of key pharmaceutical products, BioMarin has developed a series of prominent brands vital for treating specific conditions. Vimizim is designed for patients with Morquio A syndrome, while Naglazyme addresses MPS VI. Both Kuvan and Palynziq are treatments for phenylketonuria, and Brineura is crafted for the treatment of CLN2 disease, a form of Batten disease. In collaboration with Sanofi Genzyme, they also market Aldurazyme for patients with MPS I. Due to the rarity of the diseases they target, BioMarin has an expansive market presence worldwide, encompassing the United States, European nations, Latin America, the Middle East, Asia, and the Pacific. The company's reach extends across many different countries, ensuring those with rare genetic diseases have access to their specialized treatments, regardless of the varied regulatory landscapes they operate within. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
My impact scoreBeta
List View
Biomarin Pharmaceutical

Around 2 billion (Bn) people worldwide lack access to essential medications1;p1. Half of the global population avoids medical care because of the out-of-pocket cost2. The annual average income in the US as of 2024 is USD69,7173.

BioMarin Pharmaceu...

Fabian N. March 26th, 2024
20 ratings
Biomarin Pharmaceutical

Research and development (R&D) investments are crucial to developing diagnostics, drugs, and vaccines that will improve and save people's lives and enhance health security1. Many health problems, cures & scientific processes, to prevent the recurr...

Ifeoluwa I. January 11th, 2024
18 ratings
Biomarin Pharmaceutical

In order to ensure strong institutions and the well-being of society, governments spend a considerable amount of the state's budget on public goods and services, which are funded by taxes paid by individuals and corporations1. On average, the stat...

Ajay A. February 13th, 2024
20 ratings
Biomarin Pharmaceutical

Packaging waste leakage has significantly increased in recent years1, wherein 40% of plastic waste ends up in landfills1. Pharmaceutical waste includes hazardous and non-hazardous wastes, including expired, unused, and used packaging, mostly plast...

Rasheed S. September 8th, 2023
14 ratings
Biomarin Pharmaceutical

In 2022 3.32 billion people were employed globally1. Job creation assists society in many ways, such as eliminating poverty and bringing economic stability, eventually leading to new taxpayers2. It also gives opportunities for personal growth and ...

Rebecca L. August 16th, 2023
26 ratings
Biomarin Pharmaceutical

Discrimination makes it harder for minorities to meet basic financial requirements1. Increasing minority representation improves their economical & psychological conditions1. Hispanics/Latinos (H/L), Blacks/African Americans (B/AA), Asians, Americ...

Rebecca L. June 17th, 2023
20 ratings
Biomarin Pharmaceutical

As per the ILO, to be gender-balanced, an organization needs 40-60% of either gender1;pxii. An upper ratio of women in the workplace forecasts more job satisfaction, meaningful work, dedication, and fewer burnouts2Conversely, women's underrepres...

Rams R. December 3rd, 2023
18 ratings
Biomarin Pharmaceutical

Neuronal ceroid lipofuscinosis 2 (CLN2 or Batten disease) is a rare progressive nervous system disease that affects kids between ages 2-4; general symptoms are speech delay, seizures, loss of muscle coordination, muscle twitches, loss of vision, d...

Claudia M. July 27th, 2023
40 ratings
Biomarin Pharmaceutical

Diseases and illness are leading causes of death globally1. There were 55.4M deaths worldwide in 2019, and diseases were responsible for 74% of them1. The pharmaceutical industry has a crucial role in preventing these deaths, as it involves resear...

Ardit N. October 21st, 2022
38 ratings
Biomarin Pharmaceutical

Global GHG emissions were reported to be around 59.1Bn tonnes in 20191and around 36Bn tonnes of COis emitted globally every year2. Wildfires, rise in global temperature, and extreme weather conditions are a few effects that GHG emission causes...

Shahnaz S. September 15th, 2021
26 ratings

Most negative / positive SDG

+2.53
-2.81